VIC Announces Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation

VIC adds two life science leaders, bringing additional key insight to the team. VIC Technology Venture Development, which creates and develops high impact life science companies based on technologies exclusively...

Nob Hill Therapeutics Adds Seasoned Life Science Expert Paul Atkins as Executive Chairman

Atkins will bring critical insight into the development and commercialization of inhaled medicines Albuquerque, NM - Southwest-based start-up Nob Hill Therapeutics is pleased to announce that Dr. Paul Atkins has been...

The Accelerating Pace of Life Science Innovation in a (Soon-to-Be) Post-Pandemic World

As discussed in my previous article “Portfolio Diversification During Times of Market Volatility,”[1] one of the few positive outcomes of the worldwide pandemic is the increasing recognition of the power of innovation...

Akeso Biomedical Announces European Food Safety Authority Positive Scientific Opinion

Akeso Biomedical is pleased to announce that the European Food Safety Authority (EFSA) provided a positive scientific opinion for use of its CI-FER™ feed additive in weaners. The positive opinion was provided after the...

VIC Technology Venture Development Announces New Board of Directors Appointment

VIC Adds Acclaimed Life Science Veteran to Their Team. Fayetteville, AR - VIC Technology Venture Development announced today the appointment of Fenel M. Eloi, a seasoned executive in the life science sector, to their...

Inside CU Innovations: An Interview with Executive Director, Kim Muller

Kim Muller is the Executive Director of CU Innovations, the technology commercialization and venture development office at the University of Colorado’s Anschutz Medical and Denver campuses. We recently had a chance to...

From the Corner Office: Solenic Medical Reaches a Two-Year Anniversary Milestone

The two-year anniversary point in any startup provides an opportunity to reflect on the surprises and unexpected turns in the road, many of which could not have been predicted. Solenic Medical’s second year was unlike...

Zebra Analytix Receives NIH Grant for Rapid Breath Detection of Hazardous Substance Exposure

FAYETTEVILLE, AR - Zebra Analytix, Inc.—a VIC Technology Venture Development portfolio company—announced today that it has been awarded a National Institutes of Health (NIH) Small Business Innovation Research (SBIR)...

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

VIC Foundry, in collaboration with Sandia National Laboratories, is developing a self-contained isothermal nucleic acid amplification test to address an unmet need for at-home testing of COVID-19 infection. This...

VIC 2020 Annual Report Executive Summary

Despite the challenges 2020 brought, we saw promising progress for VIC and our portfolio companies. Click Here to download the The Annual Report Executive Summary or view it below.

FEATURED RESOURCES

Insight
Zero Federal Capital Gains Taxes on High-Return Investments
White Paper
Portfolio Diversification in Times of Market Volatility
Insight
Protecting Early Investors in Capital-Intensive Life Science Companies
Interview
Inside CU Innovations: An Interview with Executive Director, Kim Muller
White Paper
Accessing Innovation Directly from the Source - Growing Trends in Venture Capital Company Formation
Updates
VIC Technology Venture Development Announces New Board of Directors Appointment
News
VIC Portfolio Company, BlueInGreen, Acquired by Chart Industries
Interview
VIC Fellows Spotlight: Michael Gaspar, MD
From The Corner Office
Vixiar: Solving a Big Problem With a Small Device